| Income Statement |
| Total Revenue | 14.29M |
|
| Revenues (USD) | 14.29M |
| Cost of Revenue | 1.27M |
| Gross Profit | 13.01M |
| Operating Expenses | 58.83M |
| Research and Development Expense | 29.37M |
| Selling, General and Administrative Expense | 29.47M |
| Operating Income | -45.82M |
| Net Income | -44.39M |
| Net Income Common Stock | -44.39M |
| Net Income Common Stock (USD) | -44.39M |
| Consolidated Income | -44.39M |
| Earnings per Basic Share | -0.14 |
| Earnings per Basic Share (USD) | -0.14 |
| Earnings per Diluted Share | -0.14 |
| Earning Before Interest & Taxes (EBIT) | -44.39M |
| Earning Before Interest & Taxes (USD) | -44.39M |
| Weighted Average Shares | 320.44M |
| Weighted Average Shares Diluted | 320.44M |
| Balance Sheet |
| Cash and Equivalents | 160.08M |
| Cash and Equivalents (USD) | 160.08M |
| Trade and Non-Trade Receivables | 11.22M |
| Current Assets | 182.11M |
| Property, Plant & Equipment Net | 10.25M |
| Total Assets | 218.88M |
| Debt Current | 1.62M |
| Total Debt | 8.39M |
| Current Liabilities | 31.03M |
| Debt Non-Current | 6.78M |
| Total Liabilities | 37.80M |
| Accumulated Retained Earnings (Deficit) | -1.04B |
| Accumulated Other Comprehensive Income | -35.00K |
| Shareholders Equity | 181.08M |
| Shareholders Equity (USD) | 181.08M |
| Assets Non-Current | 36.77M |
| Total Debt (USD) | 8.39M |
| Inventory | 25.35M |
| Liabilities Non-Current | 6.78M |
| Trade and Non-Trade Payables | 9.49M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 639.00K |
| Net Cash Flow from Financing | 19.44M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -24.07M |
| Capital Expenditure | -510.00K |
| Issuance (Purchase) of Equity Shares | 19.59M |
| Net Cash Flow from Investing | -510.00K |
| Net Cash Flow from Operations | -43.00M |
| Share Based Compensation | 2.90M |